Visby Medical, Inc. news
isby Medical, a leading medical diagnostic company, today announced the appointment of John W. Kuo as the company’s new Chief Legal Officer. An experienced veteran in corporate law, Kuo brings more than 30 years of experience across multiple industries, including nearly 20 years in the healthcare industry.
Visby Medical™, a leading medical diagnostic company, today announced the appointment of John W. Kuo as the company’s
The Body Agency Collective, Visby Medical, Inc. and CCHCI observe National STD Awareness Month with women’s health initiative on US-Mexico border.
CCHCI among first healthcare providers in the nation to adopt new handheld PCR technology to detect gonorrhea, chlamydia and trichomoniasis in a single visit.
Chiricahua Community Health Centers, Inc. (CCHCI) today announced a collaboration with
Visby Medical™, a leading medical diagnostic company, today announced Everett Cunningham has been appointed to the company’s Board of Directors. Cunningham is currently Chief Commercial Officer at Exact Sciences and brings 30 years of commercial experience in pharmaceuticals and molecular diagnostics to the company’s board.
“I am thrilled to welcome Everett to the Visby team,” said Visby Medical Founder and CEO
Visby Medical, Inc. an innovative diagnostic company, today announced its agreement with Urgent Care for Children (UC4C) to offer the company’s new Sexual Health Click Test to patients for the detection of sexually transmitted infections (STIs) in female patients 14 years of age and older. The device can detect chlamydia, gonorrhea, and trichomoniasis, three of the most common and curable STIs, with about 97 percent or greater accuracy. According to the Centers for Disease Control and P
Visby Medical™, a leading medical diagnostic company, today announced that it has received an additional $25.5M in federal funding to develop and validate an at-home combination Flu-Covid test from the Biomedical Advanced Research and Development Authority (BARDA).The developmental-stage Flu-COVID PCR Test is a single-use, handheld, all-in-one PCR device that detects and distinguishes between influenza A, influenza B, and SAR
Visby Medical™, a leading medical diagnostic company, today announced that it has raised over $100 million in its Series E financing round, with investment led by Ping An Voyager Partners and joined by the Healthcare of Ontario Pension Plan (HOOPP). The round also included participation by existing investors including John Doerr, Cedars Sinai Medical Center, ND Capital, Artiman Ventures, Pitango Venture Capital, Blue Water Life Science Advisor
Visby Medical™, a leading medical diagnostic company, today announced that it will make its debut appearance at the 40th Annual J.P. Morgan Healthcare Conference. Visby Founder and CEO Adam de la Zerda, PhD, will present virtually on Thursday, January 13, 2022, at 10:30 a.m. ET. During his presentation, de la Zerda will provide an overview of Visby’s latest developments in hand-held PCR technology, key strategic priorities for 2022 and the future of diagnostics i
Visby Medical™, a leading medical diagnostic company, today announced Terri Bresenham and Scott Mendel have been appointed to the company’s Board of Directors. Bresenham was most recently chief innovation officer at General Electric Corporation and Mendel was chief executive officer of GenMark Diagnostics. Together they bring over 45 cumulative years of experience in the medical device industry to the company’s board.
&ldqu
Visby Medical™, a leading medical diagnostic company, today announced results from the cross-sectional single visit patient outcomes and implementation study, which evaluated self-collected vaginal swab samples from 55 women using the Visby Medical Sexual Health Click Test for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV).
The results of this IRB-approved study are now published
Visby Medical™, a leading medical diagnostic company, today announced Thomas Prescott, former president and chief executive officer (CEO) of Align Technology and Cardiac Pathways, will join as the company’s new chairman of the board. In his new role, Prescott will lead the Board of Directors and provide strategic counsel on critical growth initiatives for the company.
“I am excited to welcome Tom to the Visby team,” said Visby Medical Founder and CEO Adam de la